Is Deepak Nitrite (DEEPAKNTR) overvalued or fairly valued?

MarketChacha shows Deepak Nitrite's valuation in context — a forward P/E of about 27.8, a price-to-book of about 4.0 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is Deepak Nitrite's revenue?

Deepak Nitrite reported revenue of ₹7,887 Cr for FY2026, with net profit of ₹551 Cr, per official filings.

What is the share price of Deepak Nitrite (DEEPAKNTR)?

Deepak Nitrite last traded at ₹1,712.40 (-0.7% on the day), as of 9/4/2026 — a delayed quote shown for education, not investment advice.

Deepak Nitrite

DEEPAKNTR · NSE · Chemicals · India

Snapshot

TickerDEEPAKNTR

ExchangeNSE

SectorChemicals

CountryIndia

Employees1,447

HeadquartersVadodara, India

Websitewww.godeepak.com

Filings tracked10

About Deepak Nitrite

Deepak Nitrite Limited manufactures, trades, and sells chemical intermediates in India and internationally. It operates through Advanced Intermediates and Phenolics segments. The company offers sodium nitrite, sodium nitrate, nitro toluidines, fuel additives, nitrosylsulfuric acid, xylidines, oximes, cumidines, speciality agrochemicals, optical brighteners, nitric acid, fluorinated compounds, DASDA, benzotrifluoride, cumene, phenol, acetone, isopropyl alcohol, and alpha methyl styrene. It also provides 2 MePPDA, 2,3-xylidine, 2,4-xylidine, 2,6-xylidine, 2-ethylhexyl nitrate, 3-NOX, 4-NOX; 2B, 4BBT, ABP, ABP X, and BMK deepwhite powders; 2BL, ABP, AS, BA, BHT HC, DSP, MST, SPF Z, SI, UBR, UP, and XBE deepwhite liquids; 4BB conc, 4BB conc T, DMA-X, DMA-X conc, and UFD slurry deepwhite products; IPA, MAHCL, mHBTF, MMDPA, MNT(3- nitrotoluene), MT(m-toluidine), ONT(2- nitrotoluene), OT(o-toluidine), PNT(4- nitrotoluene), and PT(p-toluidine); B+ (brown colour), FX (yellow colour), and GLP (yellow colour) protecto products; ortho and para cumidines; and TFMAP, as well as project management consultancy services and manufactures polycarbonate compounds. The company serves colourants, dyes, rubber, paper, agrochemicals, pharmaceuticals, personal care, water treatment, glass, explosives, textiles, laminate and plywood, automotive, construction, adhesives, and sanitisers industries. Deepak Nitrite Limited was incorporated in 1970 and is headquartered in Vadodara, India.

Who owns it

Promoters49.8%
Institutions25.4%
Public & other24.8%

63 institutional holders

Ownership breakdown from public market data. Promoter pledge is not included here — that comes from exchange shareholding filings.

Forensic scorecard

Margin has compressed by about 3.7 points over the period — profitability is trending down.

Net margin trend10.7% → 7.0%

Margin has compressed by about 3.7 points over the period — profitability is trending down.

Growth qualityrev -0% · PAT -14%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (Yahoo Finance). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev ₹2,165 Cr

Next fiscal year

Rev ₹10,357 Cr · EPS 62.04

Est. earnings growth -6.7%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: Yahoo Finance

Annual

Quarterly · last 5

Revenue (FY2026)

₹7,887 Cr

Net margin

7.0%

Revenue CAGR (3y)

-0.4%

Profit CAGR (3y)

-13.5%

Net profit (FY2026)

₹551 Cr

Ask MarketChacha about DEEPAKNTR

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	Net margin
FY2026	₹7,887 Cr	₹551 Cr	7.0%
FY2025	₹8,282 Cr	₹697 Cr	8.4%
FY2024	₹2,724 Cr	₹811 Cr	29.8%
FY2023	₹7,972 Cr	₹852 Cr	10.7%

Quarterly

Period	Revenue	Net profit	Net margin
Q1 FY27	₹807 Cr	₹345 Cr	42.8%
Q4 FY26	₹2,120 Cr	₹220 Cr	10.4%
Q3 FY26	₹694 Cr	₹100 Cr	14.4%
Q2 FY26	₹1,902 Cr	₹119 Cr	6.2%
Q1 FY26	₹1,890 Cr	₹112 Cr	5.9%

Figures as reported, in ₹ (crore). Source: Yahoo Finance.

Filings & announcements

2026

Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
BSE8/26/2026
Change in Management
Disclosure under Regulation 30 of SEBI LODR Regulations - Resignation of Shri Puneet Sharma, SBU Head - Life Sciences of the Company
BSE8/21/2026
Earnings Call Transcript
Earnings Call Transcript Q1 FY 2027
BSE8/11/2026
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
BSE8/7/2026
Change in Management
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
BSE8/7/2026
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results of 55th Annual General Meeting held on 5th August, 2026
BSE8/5/2026material
Proceedings Of 55Th Annual General Meeting
Proceedings of 55th Annual General Meetings
BSE8/5/2026material
Q1 -FY 2027 Investor Presentation
Q1 - FY 2027 Investor Presentation
BSE8/4/2026
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
BSE7/28/2026
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
BSE7/23/2026

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.